Hooper’s big pay day
September 10, 2013
SIGMA Pharmaceuticals
managing director Mark Hooper
last Friday received shares worth
more than $2.6 million in the
company, after 4,051,237 “sign
on performance rights” he first
received when he took the job
were converted to shares.
Hooper was appointed Sigma md
just over three years ago (PD 17
Jun 10), replacing the company’s
former ceo Elmo de Alwis.
The performance rights
became ordinary shares because
“performance conditions under the
sign on performance rights were
met,” according to an ASX update.
Hooper also holds more than 15.7
million shares under the company’s
“loan funded long term incentive
plan” as well as 13,612 employee
share plan shares and 345,627
more performance rights under his
short term incentive plan.
The above article was sent to subscribers in Pharmacy Daily's issue from 10 Sep 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 10 Sep 13
